What type of study is this?

September 28, 2025Advances in RheumatologyOpen Access

The vital role of CD19+CD24hiCD38hi regulatory B cells in rheumatoid arthritis: correlations with disease activity and treatment response

View Full Paper

Ask AI

Bookmark

A significant increase in cd19+cd24hicd38hi breg levels was observed after six months of treatment, highlighting their potential as biomarkers.
Patients displayed a positive correlation between cd19+cd24hicd38hi breg levels and morning stiffness duration, suggesting possible involvement in disease manifestation.
In a cohort of 90 newly diagnosed ra patients and 32 healthy controls, the study assessed breg levels and their association with clinical indicators.
Further research is warranted to clarify the biological mechanisms connecting bregs with disease activity and inflammatory processes in ra.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Observational study examines CD19+CD24hiCD38hi regulatory B cells in rheumatoid arthritis, indicating potential biomarkers for disease activity and treatment response.

Cite This Study

Chen et al. (2025) studied this question.

synapsesocial.com/papers/68d9052941e1c178a14f5a56 https://doi.org/10.1186/s42358-025-00474-3

View Full Paper

Ask AI

Bookmark

Implication

Observational study examines CD19+CD24hiCD38hi regulatory B cells in rheumatoid arthritis, indicating potential biomarkers for disease activity and treatment response.

The vital role of CD19+CD24hiCD38hi regulatory B cells in rheumatoid arthritis: correlations with disease activity and treatment response

Key Points

Discussion

Implication

Cite This Study

The vital role of CD19+CD24hiCD38hi regulatory B cells in rheumatoid arthritis: correlations with disease activity and treatment response

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider